We describe the first direct structural characterization of medium-sized ruthenium clusters (Ru19 (-) , Ru28 (-) , Ru38 (-) , and Ru44 (-) ) by using a combination of trapped ion electron diffraction and density functional theory. We find close-packed structures based on octahedral geometries: Ru19 (-) and Ru44 (-) are closed-shell octahedra whereas Ru28 (-) is a double octahedron. In the case of Ru38 (-) , instead of a truncated octahedron we obtain evidence for lower symmetry structures containing a reentrant surface.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cphc.201400011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Plaque Radiotherapy for Ocular Melanoma.
Cancers (Basel)
October 2024
Department of Ophthalmology, National University Health System, Singapore 119228, Singapore.
Article Synopsis
- Plaque radiotherapy is a targeted treatment for medium-sized ocular tumors like uveal melanoma, using customized plaques to deliver precise radiation while minimizing damage to surrounding healthy tissue.
- The choice of radioisotope, such as Ruthenium-106 or Iodine-125, is based on factors like tumor characteristics and desired treatment duration, with high dose rate (HDR) options facilitating quicker treatment.
- Efficacy of Ruthenium-106 varies significantly, and outcomes can be influenced by tumor size, thickness, and location; however, plaque brachytherapy can offer similar survival rates to more invasive treatments like enucleation for suitable cases.
Quantifying the effect of eccentric ruthenium plaque placement on tumor volume dose.
J Contemp Brachytherapy
December 2023
Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.
Purpose: Ruthenium-106 brachytherapy is a common treatment for small to medium-sized uveal melanomas. In certain clinical contexts, plaques may be placed eccentrically to tumor center. The effect of plaque decentration, a common radiation dose measurement in radiotherapy: D, the percentage of the tumor volume receiving at least 98% of the prescribed dose (a commonly used term in radiation oncology), is unknown.
View Article and Find Full Text PDFRuthenium-Catalyzed Carbonylation of α-Aminoaryl-Tethered Alkylidenecyclopropanes: Synthesis of Eight-Membered Benzolactams.
Org Lett
January 2024
School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, Guangdong 529020, P. R. China.
The synthesis of medium-sized lactams is a great challenge because of the unfavorable transannular interactions and entropic barriers in the transition state. We have developed a ruthenium-catalyzed carbonylation of α-aminoaryl-tethered alkylidenecyclopropanes (ACPs) that allows for the efficient preparation of valuable eight-membered benzolactams under ligand-free conditions. The amino group served a dual role of both directing group and nucleophile to facilitate the metallacycle formation and the carbonylation.
View Article and Find Full Text PDFRuthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results.
BMC Ophthalmol
July 2022
Eye Research Center, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Background: To report the long-term outcomes of Ru-106 plaque radiotherapy in eyes with uveal melanoma (UM) and to assess the effect of tumor thickness and location on final outcomes.
Methods: Medical records of 234 patients undergoing Ru-106 plaque radiotherapy for UM were reviewed, and the visual outcome, globe preservation, and patient survival were evaluated. The results of 2 groups were compared: 1.
Ultrasmall Ruthenium Nanoparticles with Boosted Antioxidant Activity Upregulate Regulatory T Cells for Highly Efficient Liver Injury Therapy.
Small
July 2022
Institute of Pharmaceutics, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
Nanozymes exhibiting antioxidant activity are beneficial for the treatment of oxidative stress-associated diseases. Ruthenium nanoparticles (RuNPs) with multiple enzyme-like activities have attracted growing attention, but the relatively low antioxidant enzyme-like activities hinder their practical biomedical applications. Here, a size regulation strategy is presented to significantly boost the antioxidant enzyme-like activities of RuNPs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!